AAN 2016: Highlights of the American Academy of Neurology Meeting

New discoveries on ALS risk factors and biomarkers were among the highlights on ALS presented at the Annual American Academy of Neurology (AAN) Meeting, held April 15-21 in Vancouver, British Columbia. Researchers presented findings on dipeptide repeat proteins as potential biomarkers of C9ORF72 ALS, as well as on clinical features associated with the C9ORF72 and the TBK1 mutations (see Feb 2015 news).  Also featured were presentations on APOE2 as a risk factor for dementia in ALS (see Mar 2016 news), and on the utility of slow vital capacity (SVC) as an outcome measure in drug trials.

Click here to read the AAN conference report from The ALS Association.

apoe2 conf-american-academy-of-neurology-annual-meeting disease-als disease-ftd topic-clinical topic-preclinical
Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail